Laporan Laba Rugi (TTM)
Laporan Laba Rugi Alnylam Pharmaceuticals, Inc. - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 401 | 493 | 571 | 688 | 749 | 844 | 880 | 884 | 961 | 1,037 | 1,143 | 1,237 | 1,724 | 1,828 | 2,003 | 2,344 | 2,095 | 2,248 | 2,348 | 2,462 |
| Change (%) | 22.91 | 15.84 | 20.42 | 8.99 | 12.67 | 4.23 | 0.48 | 8.67 | 7.96 | 10.22 | 8.22 | 39.29 | 6.07 | 9.57 | 17.03 | -10.65 | 7.33 | 4.44 | 4.85 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 67 | 78 | 96 | 115 | 126 | 140 | 145 | 147 | 155 | 169 | 188 | 233 | 276 | 310 | 322 | 305 | 306 | 323 | 328 | 403 |
| Change (%) | 16.14 | 22.75 | 19.65 | 9.48 | 11.66 | 3.26 | 1.42 | 5.76 | 8.76 | 11.40 | 23.70 | 18.57 | 12.54 | 3.58 | -5.19 | 0.52 | 5.53 | 1.57 | 22.62 | |
| % of Revenue | 16.76 | 15.84 | 16.78 | 16.67 | 16.75 | 16.60 | 16.44 | 16.60 | 16.15 | 16.27 | 16.45 | 18.80 | 16.00 | 16.98 | 16.05 | 13.00 | 14.63 | 14.38 | 13.99 | 16.36 |
| Gross Operating Profit | 334 | 415 | 475 | 573 | 624 | 704 | 735 | 737 | 806 | 869 | 955 | 1,005 | 1,448 | 1,518 | 1,682 | 2,040 | 1,788 | 1,925 | 2,020 | 2,059 |
| Change (%) | 24.28 | 14.54 | 20.58 | 8.89 | 12.88 | 4.42 | 0.30 | 9.25 | 7.81 | 9.99 | 5.17 | 44.09 | 4.84 | 10.80 | 21.27 | -12.32 | 7.63 | 4.92 | 1.96 | |
| % of Revenue | 83.24 | 84.16 | 83.22 | 83.33 | 83.25 | 83.40 | 83.56 | 83.40 | 83.85 | 83.73 | 83.55 | 81.20 | 84.00 | 83.02 | 83.95 | 87.00 | 85.37 | 85.62 | 86.01 | 83.64 |
| SG&A | 646 | 588 | 663 | 662 | 619 | 621 | 628 | 653 | 747 | 771 | 800 | 845 | 808 | 796 | 823 | 856 | 878 | 976 | 1,005 | 1,080 |
| Change (%) | -8.95 | 12.60 | -0.04 | -6.59 | 0.32 | 1.23 | 3.93 | 14.36 | 3.21 | 3.79 | 5.59 | -4.34 | -1.51 | 3.41 | 4.10 | 2.55 | 11.07 | 2.99 | 7.46 | |
| % of Revenue | 161.17 | 119.39 | 116.05 | 96.33 | 82.56 | 73.51 | 71.39 | 73.84 | 77.71 | 74.29 | 69.95 | 68.25 | 46.87 | 43.52 | 41.07 | 36.53 | 41.93 | 43.39 | 42.79 | 43.85 |
| R&D | 620 | 655 | 617 | 662 | 713 | 792 | 776 | 799 | 850 | 883 | 944 | 987 | 994 | 1,004 | 1,035 | 1,080 | 1,098 | 1,126 | 1,130 | 1,160 |
| Change (%) | 5.65 | -5.76 | 7.35 | 7.71 | 11.03 | -2.02 | 2.97 | 6.36 | 3.88 | 6.87 | 4.54 | 0.79 | 1.02 | 3.03 | 4.41 | 1.64 | 2.55 | 0.37 | 2.61 | |
| % of Revenue | 154.57 | 132.86 | 108.08 | 96.35 | 95.22 | 93.83 | 88.20 | 90.39 | 88.46 | 85.12 | 82.53 | 79.72 | 57.69 | 54.94 | 51.66 | 46.09 | 52.43 | 50.09 | 48.14 | 47.11 |
| OpEx | 1,333 | 1,321 | 1,375 | 1,439 | 1,458 | 1,553 | 1,549 | 1,599 | 1,752 | 1,822 | 1,932 | 2,064 | 2,078 | 2,110 | 2,179 | 2,242 | 2,283 | 2,425 | 2,463 | 2,642 |
| Change (%) | -0.90 | 4.10 | 4.65 | 1.27 | 6.54 | -0.25 | 3.21 | 9.57 | 4.03 | 5.99 | 6.84 | 0.69 | 1.56 | 3.25 | 2.87 | 1.84 | 6.23 | 1.58 | 7.25 | |
| % of Revenue | 332.51 | 268.09 | 240.91 | 209.35 | 194.53 | 183.93 | 176.04 | 180.82 | 182.32 | 175.68 | 168.93 | 166.78 | 120.56 | 115.43 | 108.78 | 95.62 | 108.98 | 107.87 | 104.91 | 107.32 |
| Operating Income | -932 | -828 | -805 | -752 | -708 | -709 | -669 | -715 | -791 | -785 | -788 | -826 | -354 | -282 | -176 | 103 | -188 | -177 | -115 | -180 |
| Change (%) | -11.14 | -2.89 | -6.55 | -5.79 | 0.05 | -5.58 | 6.80 | 10.69 | -0.75 | 0.39 | 4.84 | -57.11 | -20.38 | -37.70 | -158.38 | -283.29 | -5.98 | -34.78 | 56.18 | |
| % of Revenue | -232.51 | -168.09 | -140.91 | -109.35 | -94.53 | -83.93 | -76.04 | -80.82 | -82.32 | -75.68 | -68.93 | -66.78 | -20.56 | -15.43 | -8.78 | 4.38 | -8.98 | -7.87 | -4.91 | -7.32 |
| Interest Expense | -56 | -84 | -117 | -123 | -135 | -143 | -153 | -162 | -163 | -156 | -143 | -130 | -120 | -121 | -128 | -131 | -134 | -142 | -145 | -152 |
| Change (%) | 50.94 | 38.48 | 5.27 | 9.37 | 6.16 | 6.89 | 6.01 | 0.50 | -4.24 | -8.60 | -8.82 | -7.84 | 1.19 | 5.20 | 2.53 | 2.66 | 5.69 | 2.39 | 4.81 | |
| % of Revenue | -13.96 | -17.14 | -20.49 | -17.92 | -17.98 | -16.94 | -17.37 | -18.33 | -16.95 | -15.03 | -12.47 | -10.50 | -6.95 | -6.63 | -6.37 | -5.58 | -6.41 | -6.31 | -6.19 | -6.18 |
| Net Income | -891 | -858 | -876 | -887 | -838 | -853 | -893 | -981 | -1,182 | -1,131 | -1,065 | -1,064 | -510 | -440 | -332 | -73 | -332 | -278 | -270 | -319 |
| Change (%) | -3.66 | 2.11 | 1.18 | -5.50 | 1.78 | 4.70 | 9.84 | 20.54 | -4.31 | -5.86 | -0.13 | -52.06 | -13.66 | -24.57 | -78.03 | 355.52 | -16.28 | -3.04 | 18.31 | |
| % of Revenue | -222.19 | -174.15 | -153.49 | -128.97 | -111.82 | -101.01 | -101.47 | -110.91 | -123.02 | -109.04 | -93.13 | -85.95 | -29.58 | -24.08 | -16.58 | -3.11 | -15.86 | -12.37 | -11.49 | -12.96 |
Source: Capital IQ
